source
- FDA approves all-oral decitabine/cedazuridine plus venetoclax for older or unfit AML patientsThe FDA has granted approval for the combination of decitabine and cedazuridine (Inqovi) with venetoclax (Venclexta) to treat newly diagnosed acute myeloid leukemia in adults who are at least 75 ye…
- FDA grants accelerated approval to sonrotoclax for relapsed/refractory mantle cell lymphomaThe U.S. Food and Drug Administration has granted accelerated approval to sonrotoclax (brand name Beqalzi) for adult patients with relapsed or refractory mantle cell lymphoma who have received at l…